In the context of cardiac hypertrophy, inhibition of STAT3 signaling is generally protective [13,17–20], suggesting antagonizing JAK1 signaling in adulthood may even be antihypertrophic and cardioprotective. The gene discussed is STAT3; the disease is cardiac hypertrophy.